Riccardo B.
- Country
- Italy
- Department
- Ematology
Research Overview
- Phase I-II Study of Romidepsin Combined with CHOEP for Initial Treatment in Young Patients with Nodal Peripheral T-Cell Lymphomas Prior to Hematopoietic Stem Cell Transplantation
- Venetoclax in combination with the BTK inhibitor Ibrutinib and Rituximab or conventional chemotherapy (Bendamustine) and Ibrutinib and Rituximab in patients with treatment naive Mantle Cell Lymphoma not eligible for high dose therapy
- A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, versus Standard of Care Therapy in Participants with Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma (OLYMPIA-4)
Data & Insights
Has run more than one trial at 176 of 362 partner sites.
Specializations
B-Cell Lymphoma Expertise
The investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on Diffuse Large B-Cell Lymphoma (DLBCL). Their research encompasses both newly diagnosed and relapsed/refractory cases.
- Advanced DLBCL Treatments
- Novel Therapeutic Combinations
- High-risk B-cell Lymphoma Management
Mantle Cell Lymphoma Studies
Extensive work in Mantle Cell Lymphoma (MCL) treatment, focusing on innovative therapeutic approaches and combinations. The investigator explores various treatment strategies including targeted therapies and immunochemotherapy protocols.
- Combined Therapy Approaches
- Elderly Patient Care
- Novel Agent Integration
T-Cell Lymphoma Research
Specialized focus on T-cell lymphoma variants, including Peripheral T-cell Lymphoma and Anaplastic Large T-cell Lymphoma. The investigator works with innovative treatment protocols for these rare lymphoma subtypes.
- First-line Treatment Strategies
- Stem Cell Transplantation Approaches
- Novel Therapeutic Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.